Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy

References

• Kang JG, Ahn HJ, Kim GS, Hahm TS, Lee JJ, Gwak MS, Choi SJ. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4). Anesth Analg 2006; 103:1543–8.
   Google Scholar
• Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010;104: 318–25.
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324–9.
   PubMed Web of Science ®Google Scholar
• Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011;37:1725–37.
   PubMed Web of Science ®Google Scholar
• Levi M, Jonge E. Clinical relevance of the effects of plasma expanders on coagulation. Semin Thromb Hemost 2007; 33:810–5.
   PubMed Web of Science ®Google Scholar
• Marx G, Schuerholz T. Fluid-induced coagulopathy: does the type of fluid make a difference?Crit Care 2010; 14:118.
   PubMed Web of Science ®Google Scholar
• Jungner M, Bentzer P, Grände PO. Intracranial pressure following resuscitation with albumin or saline in a cat model of meningitis. Crit Care Med 2011;39:135–40.
   PubMed Web of Science ®Google Scholar
• Jungner M, Grände PO, Mattiasson G, Bentzer P. Effects on brain edema of crystalloid and albumin fluid resuscitation after brain trauma and hemorrhage in the rat. Anesthesiology 2010;112:1194–203.
   PubMed Web of Science ®Google Scholar
• Winstedt D, Hanna J, Schött U. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest 2013;73:161–9.
   PubMed Web of Science ®Google Scholar
• Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005;49:1163–71.
   PubMed Web of Science ®Google Scholar
• Roche AM, James MF, Bennett-Guerrero E, Mythen MG. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006; 102:1274–9.
   PubMed Web of Science ®Google Scholar
• Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373–8.
   Google Scholar
• Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J, Engdahl O. The in vitro effects of crystalloids and colloids on coagulation. Anaesthesia 2002;57:1102–8.
   PubMed Web of Science ®Google Scholar
• Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998;42: 1104–9.
   Google Scholar
• Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012;114: 261–74.
   PubMed Web of Science ®Google Scholar
• Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010;105:116–21.
   PubMed Web of Science ®Google Scholar
• Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008;106:1360–5.
   PubMed Web of Science ®Google Scholar
• Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model. Blood Coagul Fibrinolysis 2012;23:370–8.
   PubMed Web of Science ®Google Scholar
• Dirkmann D, Gorlinger K, Gisbertz C, Dusse F, Peters J. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg 2012;114: 1182–8.
   Google Scholar
• Mutch NJ, Koikkalainen JS, Fraser SR, Duthie KM, Griffin M, Mitchell J, Watson HG, Booth NA. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost 2010;8:2017–24.
   Web of Science ®Google Scholar
• Schramko AA, Kuitunen AH, Suojaranta-Ylinen RT, Niemi TT. Role of fibrinogen-, factor VIII- and XIII- mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 2009;53:731–5.
   PubMed Web of Science ®Google Scholar
• Sørensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012;99(Suppl. 1):40–50.
   Google Scholar
• Howard BM, Daley AT, Cohen MJ. Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions. Semin Thromb Hemost 2012;38: 250–8.
   Google Scholar
• Maegele M, Spinella PC, Schöchl H. The acute coagulopathy of trauma: mechanisms and tools for risk stratification. Shock 2012;38:450–8.
   PubMed Web of Science ®Google Scholar
• Ward KR. The microcirculation: linking trauma and coagulopathy. Transfusion 2013;53:38–47.
   Google Scholar
• Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Lösche W. HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 2009;13:R208.
   PubMed Web of Science ®Google Scholar
• Haas T, Korte W, Spielmann N, Mauch J, Madjdpour C, Schmugge M, Weiss M. Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth 2012;22:641–6.
   PubMed Web of Science ®Google Scholar
• Lauer P, Metzner HJ, Zettlmeissl G, Li M, Smith AG, Lathe R, Dickneite G. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 2002;88:967–74.
   Web of Science ®Google Scholar
• Nielsen VG, Kirklin JK, Hoogendoorn H, Ellis TC, Holman WL. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis 2007;18:145–50.
   Google Scholar
• Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. in vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010;104:385–91.
   PubMed Web of Science ®Google Scholar
• Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008;14:1190–200.
   PubMed Web of Science ®Google Scholar
• Weber CF, Jambor C, Marquardt M, Görlinger K, Zwissler B. Thrombelastometric detection of factor XIII deficiency. Anaesthesist 2008;57:487–90.
   Google Scholar
• Genét GF, Ostrowski SR, Sørensen AM, Johansson P. Detection of tPA-induced hyperfibrinolysis in whole blood by rapidTEG, KaolinTEG, and functional FibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 2012; 18:638–44.
   PubMed Web of Science ®Google Scholar
• Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010; 104:318–25.
   PubMed Web of Science ®Google Scholar
• Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, Wu HL, Yeh TM. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 2001;63:247–51.
   Google Scholar
• Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013;11:307–14.
   PubMed Web of Science ®Google Scholar
• Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schöchl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus 2012;13:1–9.
   Google Scholar
• Stumph MJ, Weir FW, Noall MW. Comparison of blood and brain toluene concentrations and circulating triglyceride levels resulting from acute and repeated exposures in rats. Am Ind Hyg Assoc J 1985;46:244–50.
   PubMed Web of Science ®Google Scholar
• Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 2000;93:1231–7.
   PubMed Web of Science ®Google Scholar
• Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch. N Engl J Med 2001;345:622–3.
   PubMed Web of Science ®Google Scholar
• Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan 2009;47:71–8.
   PubMedGoogle Scholar
• Innerhofer P, Fries D, Margreiter J, Klingler A, Kühbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002;95: 858–65.
   PubMed Web of Science ®Google Scholar
• Nielsen VG. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII- mediated fibrin polymer crosslinking. J Surg Res 2006; 132:17–22.
   PubMed Web of Science ®Google Scholar
• Darlington DN, Kremenevskiy I, Pusateri AE, Scherer MR, Fedyk CG, Kheirabaldi BS, Delgado AV, Dubick MA. Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood. Int J Burns Trauma 2012;2:42–50.
   Google Scholar
• Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69–73.
   Web of Science ®Google Scholar
• Stief TW. Therapeutic human albumins trigger plasmatic thrombin generation. Hemostasis Laboratory 2008;1: 185–92.
   Google Scholar
• Schols SE, Lancé MD, Feijge MA, Damoiseaux J, Marcus MA, Hamulyák K, Ten Cate H, Heemskerk JW, van Pampus EC. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010;103:318–28.
   Google Scholar
• Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. Scand J Clin Lab Invest 2012;72:121–8.
   PubMed Web of Science ®Google Scholar
• Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012;10: 1342–51.
   PubMed Web of Science ®Google Scholar
• Ternström L, Radulovic V, Karlsson M, Baghaei F, Hyllner M, Bylock A, Hansson KM, Jeppsson A. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 2010;126:128–33.
   PubMed Web of Science ®Google Scholar
• Genét GF, Johansson PI, Meyer MA, Sølbeck S, Sørensen AM, Larsen CF, Welling KL, Windeløv NA, Rasmussen LS, Ostrowski SR. Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury. J Neurotrauma 2013;30:301–6.
   Google Scholar
• Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000; 54:260–4.
   PubMedGoogle Scholar
• Gertler R, Martin K, Hapfelmeier A, Tassani-Prell P, Braun S, Wiesner G. The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery. Paediatr Anaesth 2013 May 13. doi: 10.1111/pan.12193. [Epub ahead of print]
   Google Scholar
• Idris Z, Muzaimi M, Hussin S, Mahmood WH, Abdullah WZ. Association of perioperative factor XIII activity levels and other haemostatic markers with the risk of postoperative intracranial haematoma in a selected cohort of neurosurgical patients. Acta Neurochir 2012;154: 887–93.
   Google Scholar
• Kapusta P, Wypasek E, Natorska J, Grudzien G, Sobczyk D, Sadowski J, Undas A. Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease. Thromb Haemost 2012;108:1172–9.
   Google Scholar
• Levy JH, Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2013;53:1120–31.
   PubMedGoogle Scholar
• Lawrie AS, Green L, Mackie IJ, Liesner R, Machin SJ, Peyvandi F. Factor XIII – an under diagnosed deficiency – are we using the right assays?J Thromb Haemost 2010;8:2478–82.
   Google Scholar
• Innerhofer P, Kienast J. Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 2010;24:1–14.
   Google Scholar
• Vrettou CS, Stavrinou LC, Halikias S, Kyriakopoulou M, Kollias S, Stranjalis G, Koutsoukou A. Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery. Acta Neurochir 2010;152: 529–32.
   Google Scholar
• Johansson PI, Jacobsen N, Viuff D, Olsen EH, Rojkjaer R, Andersen S, Petersen LC, Kjalke M. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers. Br J Haematol 2008;143:559–69.
   Google Scholar
• Veldman A, Neuhaeuser C, Akintuerk H, Thul J, Gehron J, Schranz D, Michel-Behnke I. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 2007;17:1176–81.
   Google Scholar
• Hildebrandt B, Machotta A, Riess H, Kerner S, Ahlers O, Haberl H, Dörken B, Kerner T. Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery – a pilot study comparing coagulation profiles in infants younger than 12 months. Thromb Haemost 2007; 98:172–7.
   Google Scholar
• Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost 2011;106:1215–23.
   Google Scholar